3002-0579 Screening compound: N-{4-[(1,3-THIAZOL-2-YLAMINO)SULFONYL]PHENYL}ISONICOTINAMIDE

3002-0579 Screening compound: N-{4-[(1,3-THIAZOL-2-YLAMINO)SULFONYL]PHENYL}ISONICOTINAMIDE
3002-0579 Screening compound: N-{4-[(1,3-THIAZOL-2-YLAMINO)SULFONYL]PHENYL}ISONICOTINAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound 3002-0579
N-{4-[(1,3-THIAZOL-2-YLAMINO)SULFONYL]PHENYL}ISONICOTINAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3002-0579

Molecular Formula

C15H12N4O3S2 (C15 H12 N4 O3 S2)

Compound Name

N-{4-[(1,3-THIAZOL-2-YLAMINO)SULFONYL]PHENYL}ISONICOTINAMIDE

IUPAC name

n/a

SMILES

O=C(c1ccncc1)Nc(cc1)ccc1S(Nc1nccs1)(=O)=O

InChI

InChI=1S/C15H12N4O3S2/c20-14(11-5-7-16-8-6-11)18-12-1-3-13(4-2-12)24(21,22)19-15-17-9-10-23-15/h1-10H,(H,17,19)(H,18,20)

InChI Key

OPDGFJDKRIBNRI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01359057

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

360.42

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.462

Distribution Coefficient, logD

1.052

Water Solubility, LogSw

-2.31

Polar Surface Area

83.886

Acid Dissociation Constant (pKa)

7.20

Base Dissociation Constant (pKb)

2.35

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

0.00

3002-0579 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-infective Library (19449 compounds)

Dark Chemical Matter Library (18430 compounds)

GPCR Targeted Library (31838 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Voltage-Gated Ion Channel-Targeted Library (4740 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Infections
  • Immune system
  • animal
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • GPCR
  • Proteases
  • Ion Channels
  • Kinases
Structure:
  • Pool
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with 3002-0579 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3002-0579?
Check Price and Availability of 3002-0579, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3002-0579 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3002-0579
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3002-0579
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3002-0579 available by request